Newsletter Subscription

Enter Name and Email

NeuroAct Communication - Newsletter - October 2010

 

Expertise in Neuropharmacology

  www.neuroact.com

 

    

 

   

Latest News

Adrian Newman-Tancredi gave an invited lecture at the 23rd meeting of the ECNP (European College of Neuropsychopharmacology).

His presentation on the pharmacology of novel antipsychotics is visible as a webcast online: Watch Webcast
 

For details of the symposium speakers
and session program:
read more.
The ECNP meeting took place from 28th August to the 1st September 2010 and attracted a record 7200 participants to Amsterdam, Netherlands.  ECNP website

 

 

 

 

 


NeuroAct Communication
is an independent consulting service founded by Adrian Newman-Tancredi Ph.D.,
an experienced pharmaceutical industry professional.

Find out more about Adrian in his Executive Profile.

NeuroAct Communication advises lifescience companies and funding agencies on neuropharmacology and central nervous system drug discovery programs.
Find out about our Consulting Services.

 

 

The NeuroAct Communication home-page
is now updated and streamlined: take a look!

 

 

New Publication

Adrian recently coauthored a publication on gene knock-down using siRNA in cell lines (see below).
Adrian has extensive experience of publication in peer-reviewed journals.
To find out how Adrian can assist you in scientific communication read more.

"Competitive interaction of 5-HT(1A) receptors with G-protein subtypes in CHO cells demonstrated by RNA interference."
Rauly-Lestienne I, Lestienne F, Ailhaud MC, Binesse J, Newman-Tancredi A, Cussac D. (2010)
Cell Signal. 2010 Aug 17. [Epub ahead of print]